These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 8787901

  • 21. Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis.
    Marangos MN, Nicolau DP, Quintiliani R, Nightingale CH.
    J Antimicrob Chemother; 1997 Apr; 39(4):519-22. PubMed ID: 9145826
    [Abstract] [Full Text] [Related]

  • 22. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.
    Gavaldà J, Pahissa A, Almirante B, Laguarda M, Crespo E, Pou L, Fernández F.
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2098-103. PubMed ID: 8540723
    [Abstract] [Full Text] [Related]

  • 23. Endocarditis due to high-level gentamicin-resistant Enterococcus faecalis.
    Lee PY, Das SS.
    Postgrad Med J; 1995 Feb; 71(832):117-9. PubMed ID: 7724425
    [Abstract] [Full Text] [Related]

  • 24. Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis.
    Luque-Paz D, Cuervo G, Miró JM, Tattevin P.
    Clin Microbiol Infect; 2023 Jun; 29(6):676-678. PubMed ID: 36889644
    [No Abstract] [Full Text] [Related]

  • 25. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM, Cervera C, Garcia-de-la-Maria C, Del Rio A, Armero Y, Mestres CA, Grau JM, Marco F, Moreno A.
    Scand J Infect Dis; 2008 Jun; 40(11-12):968-72. PubMed ID: 18767002
    [Abstract] [Full Text] [Related]

  • 26. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Simulated Endocardial Vegetations.
    Werth BJ, Shireman LM.
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
    [Abstract] [Full Text] [Related]

  • 27. Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo.
    Lefort A, Arthur M, Garry L, Carbon C, Courvalin P, Fantin B.
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2077-80. PubMed ID: 10898678
    [Abstract] [Full Text] [Related]

  • 28. Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model.
    Houlihan HH, Stokes DP, Rybak MJ.
    J Antimicrob Chemother; 2000 Jul; 46(1):79-86. PubMed ID: 10882693
    [Abstract] [Full Text] [Related]

  • 29. Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci.
    Tripodi MF, Locatelli A, Adinolfi LE, Andreana A, Utili R.
    Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):734-6. PubMed ID: 9865990
    [Abstract] [Full Text] [Related]

  • 30. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
    Fantin B, Leclercq R, Arthur M, Duval J, Carbon C.
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013
    [Abstract] [Full Text] [Related]

  • 31. Gentamicin once-daily in enterococcal endocarditis.
    Bassetti M, Righi E, Crapis M, Cojutti P, Venturini S, Viale P, Pea F.
    Int J Cardiol; 2013 Oct 12; 168(5):5033-4. PubMed ID: 23931973
    [No Abstract] [Full Text] [Related]

  • 32. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Lafaurie M, Perichon B, Lefort A, Carbon C, Courvalin P, Fantin B.
    Antimicrob Agents Chemother; 2001 Oct 12; 45(10):2826-30. PubMed ID: 11557476
    [Abstract] [Full Text] [Related]

  • 33. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
    Whitman MS, Pitsakis PG, Zausner A, Livornese LL, Osborne AJ, Johnson CC, Levison ME.
    Antimicrob Agents Chemother; 1993 Oct 12; 37(10):2069-73. PubMed ID: 8257125
    [Abstract] [Full Text] [Related]

  • 34. The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.
    Dubé L, Caillon J, Jacqueline C, Bugnon D, Potel G, Asseray N.
    Eur J Clin Microbiol Infect Dis; 2012 Oct 12; 31(10):2545-7. PubMed ID: 22395262
    [Abstract] [Full Text] [Related]

  • 35. Activity of ampicillin plus sulbactam against beta-lactamase producing enterococci in experimental endocarditis.
    Thal LA, Vazquez J, Perri MB, Beckley A, Donabedian S, Kaatz GW, Patterson JE, Zervos MJ.
    J Antimicrob Chemother; 1993 Jan 12; 31(1):182-5. PubMed ID: 8444668
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
    Pérez Salmerón J, Martínez García F, Roldán Conesa D, Lorente Salinas I, López Fornás F, Ruiz Gómez J, Gómez Gómez J, Segovia Hernández M, Valdés Chávarri M.
    Rev Esp Quimioter; 2006 Sep 12; 19(3):258-66. PubMed ID: 17099794
    [Abstract] [Full Text] [Related]

  • 38. Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis.
    Lefort A, Saleh-Mghir A, Garry L, Carbon C, Fantin B.
    Antimicrob Agents Chemother; 2000 Nov 12; 44(11):3017-21. PubMed ID: 11036016
    [Abstract] [Full Text] [Related]

  • 39. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    Thieme L, Klinger-Strobel M, Hartung A, Stein C, Makarewicz O, Pletz MW.
    J Antimicrob Chemother; 2018 Jun 01; 73(6):1553-1561. PubMed ID: 29506271
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis.
    Tran TT, Tam VH, Murray BE, Arias CA, Singh KV.
    Antimicrob Agents Chemother; 2017 Jun 01; 61(6):. PubMed ID: 28320712
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.